e-learning
resources
European Respiratory Review
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
Sake J. van der Wall, Liselotte M. van der Pol, Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter, Sam Schulman, Paolo Prandoni, Marc Rodger, Menno V. Huisman, Frederikus A. Klok
Source:
Eur Respir Rev, 27 (150) 180094; 10.1183/16000617.0094-2018
Journal Issue:
December
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sake J. van der Wall, Liselotte M. van der Pol, Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter, Sam Schulman, Paolo Prandoni, Marc Rodger, Menno V. Huisman, Frederikus A. Klok. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev, 27 (150) 180094; 10.1183/16000617.0094-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
Source: Eur Respir J 2015; 45: 201-210
Year: 2015
Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Year: 2018
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016
Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing
Source: Eur Respir J 2016; 47:1313-1314
Year: 2016
Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE)
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003
Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007
Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials
Source: Eur Respir J, 50 (3) 1701097; 10.1183/13993003.01097-2017
Year: 2017
Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism
Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018
Year: 2018
Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021
Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)?
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept